Innova Captab Ltd Share Price (INNOVACAP)

Innova Captab Ltd was incorporated as Harun Health Care Private Limited dated January 3 2005 at Mumbai. Thereafter name of the Company changed from Harun Health Care Private Limited to Innova Captab Private Limited and consequently a fresh Certificate of Incorporation dated February 2 2010 was issued by RoC to the Company. Subsequently Company converted to a Public Company on July 12 2018 and consequently its name was changed to Innova Captab Limited dated July 26 2018.The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development manufacturing drug distribution and marketing and exports. Their business includes contract development and manufacturing organization CDMO business providing manufacturing services to Indian pharmaceutical companies domestic branded generics business and an international branded generics business. Their CDMO product portfolio spans across both acute and chronic therapeutic areas. These CDMO services and products include commercial largescale manufacturing of generic products which allow customers in offering multiple dosage forms including oral solids oral liquids dry syrups and injectables modified and release forms of tablets in capsules. It has 2 manufacturing facilities in Baddi Himachal Pradesh. Their facilities further produce tablets capsules dry syrups dry powder injections ointments and liquid orals. In 2006 the first manufacturing plant got established in Baddi at Himachal Pradesh. In 2010 it commenced operations at the cephalosporin block of their plant in Baddi. In 2021 the Company acquired business of Innova Captab a Partnership Firm effective as of March 31 2021 and acquired Univentis Medicare Limited UML 100 equity shares effective on December 31 2021 and consequently The Univentis Foundation became a Subsidiary of Company on June 14 2021.The Company is planning to raise capital from Public by raising 400 crore Equity Shares through Fresh Issue and 9600000 Equity Shares through Offer for Sale..

Revenue: ₹314.74Cr as on March 2025 (Q4 FY25)
Net Profit: ₹29.57Cr as on March 2025 (Q4 FY25)
Listing date: 29 Dec, 2023